A nomogram was developed to predict postoperative complications in 207 patients with middle and low rectal cancer undergoing transanal total mesorectal excision (TATME). Findings indicated that 27.5% of patients experienced complications. Key predictors included operation time, smoking history, anastomotic technique, and ASA score, each significantly influencing risk. The model’s accuracy was validated through multiple statistical […]
Category: General Surgery
Indocyanine green fluorescence reduces anastomotic leak rates.
A systematic review and meta-analysis of six randomized trials, including 1949 patients, demonstrated that indocyanine green (ICG) fluorescence significantly reduces anastomotic leak rates in left-sided colorectal resections. The pooled odds ratio showed a 4.7% absolute reduction in leak rates (OR: 0.586, 95% CI: 0.434-0.792), indicating moderate confidence in its efficacy. ICG may serve as a […]
Achieving textbook outcomes in laparoscopic pancreatoduodenectomy is feasible.
A study involving 200 patients undergoing laparoscopic pancreatoduodenectomy demonstrated that 82.5% achieved a textbook outcome, indicating a smooth recovery without specified complications. Key independent risk factors included a higher likelihood for female patients and those with hard pancreatic texture. These findings suggest that specific patient characteristics can enhance the chances of achieving favorable surgical outcomes […]
Higher provider density correlates with reduced hepatobiliary cancer rates.
Higher county-level provider density significantly correlates with lower hepatobiliary cancer incidence and mortality. Analysis across 1,359 counties revealed that areas with low provider density suffered higher rates of all-stage and late-stage cancer incidence, along with increased mortality rates. Notably, moderate and high provider density were linked to lower odds of these outcomes. The findings advocate […]
Preoperative carbohydrate loading improves surgical outcomes in colorectal surgery.
Oral carbohydrate loading before elective colorectal surgery significantly reduces postoperative insulin resistance, inflammatory markers, and improves patient well-being. In a randomized controlled trial with 72 participants, the carbohydrate loading group showed a marked decrease in insulin resistance on the day of surgery and postoperatively. Additionally, patients experienced less thirst, hunger, and dry mouth, contributing to […]
Increased complete response rates observed in total neoadjuvant therapy
Among 339 patients with locally advanced rectal cancer, 208 (61.3%) completed total neoadjuvant therapy, achieving a final complete response (CR) rate of 42.3%. Notably, 57 patients (27.4%) sustained clinical CR for over a year, while 42 patients showed pathologic CR post-surgery. Predictors of CR included low rectal tumor location, absence of extramural vascular invasion, and […]
Conversion surgery enhances survival in previously unresectable pancreatic cancer
A multicenter study revealed that conversion surgery following FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy significantly improves overall survival in patients with initially unresectable pancreatic cancer. The surgery group demonstrated a median overall survival of 34.4 months, compared to 19.8 months in the control group (hazard ratio, 0.47). Postoperative complication rates were noted at 19.6%, with […]
CT-guided core needle biopsy is effective for pancreatic tumors
CT-guided core needle biopsy (CNB) demonstrates high diagnostic yield and safety in pancreatic tumor evaluation. In a study of 43 biopsies across 42 patients, histological diagnosis was achieved in 93% of cases. CNB exhibited a sensitivity of 93%, specificity of 100%, and overall accuracy of 93%. No major complications arose during the procedures, with most […]
Older patients with IPMNs face increased pancreatic cancer risk
Findings indicate that older age at diagnosis of intraductal papillary mucinous neoplasms (IPMNs) correlates with a heightened long-term risk of pancreatic carcinoma. In a cohort of 3,142 IPMN patients, those aged 55-64, 65-74, and ≥75 exhibited adjusted subdistribution hazard ratios of 1.80, 2.56, and 3.31 respectively, compared to those under 55. These results suggest that […]
Neoadjuvant immunochemotherapy improves outcomes for gastric cancer patients
Neoadjuvant immunochemotherapy (nict) demonstrated significant advantages over neoadjuvant chemotherapy (nct) in patients with locally advanced gastric cancer. The nict group showed higher objective response rates (79.5% vs. 59.0%) and lower early recurrence rates (29.7% vs. 40.8%). While surgical complications were similar between both treatments, nict led to better pathological response rates and acted as an […]